VALEANT PHARMACEUTICALS PHARMACEUTICAL COMPANY QUEBEC VALEANT PHARMACEUTICALS CONSUMER PRODUCTS ORAL HEALTH NEUROLOGY THERAPEUTIC ACQUIRED BAUSCH LOMB LARGEST MANUFACTURERS CONTACT LENS QUICKLY MERGERS AND ACQUISITIONS LEADERSHIP MICHAEL PEARSON SHORT PERIOD COMPANY PLATFORM COMPANY SALIX PHARMACEUTICALS BILLION TRIED ACQUIRE CEPHALON MERGE ALLERGAN FAILED INVOLVED CONTROVERSY DRUG PRICE SPECIALTY PHARMACY SPECIALTY DRUGS COMPANYS STOCK PRICE NEARLY PERCENT THE PRICE COOPERATION PHILIDOR RX SERVICES WALGREENS INVESTIGATION SECURITIES AND EXCHANGE COMMISSION BEGINNING JOSEPH PAPA LEADS BILL ACKMAN PERSHING SQUARE FUND MAJOR STAKE DRUGS THE FIELDS DERMATOLOGY INFECTIOUS DISEASE PRESCRIPTION DRUG ACNE SOLODYN ZIANA ACANYA ATRALIN MICROSPHERE WELLBUTRIN XL TREATMENT OF DEPRESSION JUBLIA TOENAIL FUNGUS TARGRETIN RETINOID CUTANEOUS LYMPHOMA ANTIBIOTIC RELATED PERIODONTITIS ZOVIRAX TOPICAL ANTIVIRAL HERPES VIRUSES PATIENTS WILSONS DISEASE ELIDEL USED TO ATOPIC DERMATITIS OVER THE COUNTER DRUG VITAMIN SKIN TREATMENT RENU LUBRICATION CONTACT LENSE LUBRICANT CLEANING CONTACT LENSES EYES MERGED CHANGED NAME MARKET CESAMET SYNTHETIC CANNABINOID THE EUROPEAN RIGHTS SWEDISH MEDA AB BOUGHT WESTERN EASTERN EUROPE BRANCHES IN SEPTEMBER CORIA LABORATORIES DOW PHARMACEUTICAL SCIENCES ANNOUNCED ACQUISITION MEXICAN GENERIC DRUG CANADIAN SUBSIDIARY OVER THE COUNTER MANUFACTURING PLANT VITAL SCIENCE ATON BIOVAIL RETAINED CANADA KEPT ATTEMPT BUY CEPHALON INC BIOVAIL CORPORATION CHAIRMAN AND CEO EUGENE MELNYK BANNED SENIOR ROLES PUBLIC COMPANIES FIVE YEARS ONTARIO SECURITIES COMMISSION THE YEAR BEFORE THE MERGER SETTLED THE UNITED STATES CIVIL PENALTY PREVIOUSLY PAID SETTLE CLAIMS ORTHO JANSSEN PHARMACEUTICALS ERTACZO ALSO KNOWN AS TRETINOIN IN AUGUST OUTSTANDING SHARES SANITAS GROUP INOVA MILESTONE PAYMENTS UP TO SANOFI SPORTS NUTRITION BIOTECHNOLOGY EYETECH ASSETS ATLANTIS IN MEXICO PLUS MEDICIS PHARMACEUTICAL THE RUSSIA NATUR PRODUKT MEDICAL PRODUCTS WARBURG PINCUS MOVE DOMINATE THE MARKET SPECIALTY SOLTA MEDICAL NESTLE THE COMMERCIAL SELL FILLER TOXIN PRECISION STRENGTHENING THE SKIN HEDGE FUND MANAGER ACTAVIS PURCHASE GASTROINTESTINAL DEVELOPER ENDO PHARMACEUTICALS MERCURY THE HOLDING AMOUN SPROUT WOMENS LIBIDO ADDYI LICENSED PSORIASIS BRODALUMAB ASTRAZENECA INTENTION EYE SURGERY PRODUCT SYNERGETICS ORDER DIVISION DOCTORS ALLERGY FORMULA GLASS LEWIS PROXY COMPENSATION DISCLOSED OFFICES THE SOUTHERN DISTRICT OF NEW PIONEERING BUSINESS MODEL OF PHARMACEUTICAL COMPANIES SALES SUPPLY CHAIN RAISING PRICES CONTEMPORANEOUS SIMILAR PHARMACEUTICAL PRODUCTS SHARES STOCKS WERE OVER WORTH HEDGE FUNDS PERSHING SQUARE CAPITAL MANAGEMENT VIKING GLOBAL INVESTORS BRAHMAN CAPITAL HERDING CORNELL UNIVERSITY PROFESSOR ANDREW OWNED VALUE HOLDINGS FALLEN INCITE PORTFOLIO MANAGERS CONTINUE FELL PER CENT ANNUAL REPORT FILED SUBJECT INVESTIGATIONS MASSACHUSETTS THE STATE OF TEXAS THE NORTH CAROLINA DEPARTMENT OF SPECIAL COMMITTEE ON AGING THE COMMITTEE OVERSIGHT DOCUMENT REQUESTS MARCHES FINANCIERS NEW JERSEY STATE BUREAU HOWARD SCHILLER THE UNITED STATES SENATE ANSWER REPERCUSSIONS HEALTH CARE SYSTEM BUSINESS THE BOARD OF DIRECTORS CEO LEAVING SOON INVESTOR ENACTED RECALL RIBAVIRIN MICROBIAL STRATEGY ACQUISITIONS MEDICAL SMALLER AWAY RESEARCH AND DEVELOPMENT SERIAL EXISTING AGGRESSIVE MARKETING RAPID MEDICINES BERKSHIRE HATHAWAY VICE CHAIRMAN CHARLIE MUNGER DEEPLY IMMORAL WORST NEGATIVE ATTENTION REGULATORS PARTICULARLY PUBLICATION THE NEW YORK TIMES ARTICLE POLLACK PRICE GOUGING POLITICIANS PRICING STRATEGIES RAISED BRAND NAME TIMES INDUSTRY THE COST FLUCYTOSINE HIGHER LATE SEPTEMBER MEMBERS OF THE UNITED STATES HOUSE COMMITTEE ON OVERSIGHT GOVERNMENT REFORM SUBPOENA DOCUMENTS THE SHARP HEART NITROPRESS ISUPREL CRITICISM NEW YORK TIMES COLUMNIST JOE NOCERA CLAIMED PLAN WAS TO FIRE SCIENTISTS JACK UP DIABETES PILL GLUMETZA THE DAY MENTION TWITTER POST PRESIDENTIAL CANDIDATE HILLARY CLINTON SPECIALTY DRUG TOMORROW TAKE IT SHE SAID GOING CAUSING FALL THE NEW YORK STOCK EXCHANGE SUBPOENAS OFFICE THE DISTRICT ATTORNEY YORK REGARDS PATIENT ASSISTANCE THE HOUSE COMMITTEE AMID PUBLIC CONCERN CITRON RESEARCH ANDREW LEFT SHORT SELLER FALSE COMPANIES ALLEGEDLY BOOKING THE PHARMACY CUSTOMERS SOLD ALLEGED PRACTICE EMPLOYEES BUSINESS OPERATIONS PHILIDOR WRITTEN COMMUNICATION ALLEGATIONS CUT IN RESPONSE ALLEGATIONS OF BILLING WALGREENS BOOTS ALLIANCE INC THE FEDERAL TRADE INVESTIGATION INTO INCREASING CONTROL PRODUCTION RIGID GAS PERMEABLE PARAGON VISION PIPELINE HARD FTCS